Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Chuma

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Hepatitis B virus management to prevent reactivation]Akito Nozaki, Makoto Chuma
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 5, 2014
New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directionsMakoto Chuma, Katsumi Terashita, Naoya Sakamoto
The American Journal of Gastroenterology|May 15, 2008
Abscopal effect on hepatocellular carcinomaMitsuru Nakanishi, Makoto Chuma, Shuhei Hige, et al.
Journal of Gastroenterology|September 22, 2006
Pulmonary tumor embolism in a case of hepatocellular carcinomaMitsuru Nakanishi, Shuhei Hige, Makoto Chuma, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Interferon therapy for chronic hepatitis B]Shuhei Hige, Takuya Sho, Mitsuru Nakanishi, et al.
Clinical Case Reports|November 16, 2022
Rapid progression of hepatocellular carcinoma in a pregnant woman: A case reportTakayoshi Iijima, Soichiro Obata, Makoto Chuma, et al.
World Journal of Hepatology|February 15, 2021
Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosisKazuo Tarao, Akito Nozaki, Makoto Chuma, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinomaTatsuhiro Shibata, Makoto Chuma, Akiko Kokubu, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|June 22, 2011
[Comprehensive strategy for extermination of hepatocellular carcinoma--prevention, diagnosis and treatment]Toshiya Kamiyama, Shuhei Hige, Yusuke Sakuhara, et al.
International Urology and Nephrology|December 16, 2006
Reactivation of hepatitis in a bladder cancer patient receiving chemotherapyHiroshi Higashiyama, Toru Harabayashi, Nobuo Shinohara, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 6, 2016
[Hepatitis B virus management to prevent reactivation]Akito Nozaki, Makoto Chuma
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 5, 2014
New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directionsMakoto Chuma, Katsumi Terashita, Naoya Sakamoto
The American Journal of Gastroenterology|May 15, 2008
Abscopal effect on hepatocellular carcinomaMitsuru Nakanishi, Makoto Chuma, Shuhei Hige, et al.
Journal of Gastroenterology|September 22, 2006
Pulmonary tumor embolism in a case of hepatocellular carcinomaMitsuru Nakanishi, Shuhei Hige, Makoto Chuma, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Interferon therapy for chronic hepatitis B]Shuhei Hige, Takuya Sho, Mitsuru Nakanishi, et al.
Clinical Case Reports|November 16, 2022
Rapid progression of hepatocellular carcinoma in a pregnant woman: A case reportTakayoshi Iijima, Soichiro Obata, Makoto Chuma, et al.
World Journal of Hepatology|February 15, 2021
Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosisKazuo Tarao, Akito Nozaki, Makoto Chuma, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinomaTatsuhiro Shibata, Makoto Chuma, Akiko Kokubu, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|June 22, 2011
[Comprehensive strategy for extermination of hepatocellular carcinoma--prevention, diagnosis and treatment]Toshiya Kamiyama, Shuhei Hige, Yusuke Sakuhara, et al.
International Urology and Nephrology|December 16, 2006
Reactivation of hepatitis in a bladder cancer patient receiving chemotherapyHiroshi Higashiyama, Toru Harabayashi, Nobuo Shinohara, et al.
Pageof 12